Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.

MLA

Chartier, Cecile, et al. “Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.” Cancer Research, vol. 76, no. 3, Feb. 2016, pp. 713–23. EBSCOhost, https://doi.org/10.1158/0008-5472.CAN-15-0561.

APA

Chartier, C., Raval, J., Axelrod, F., Bond, C., Cain, J., Dee-Hoskins, C., Ma, S., Fischer, M. M., Shah, J., Wei, J., Ji, M., Lam, A., Stroud, M., Yen, W.-C., Yeung, P., Cancilla, B., O’Young, G., Wang, M., Kapoun, A. M., … Gurney, A. (2016). Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types. Cancer Research, 76(3), 713–723. https://doi.org/10.1158/0008-5472.CAN-15-0561

Chicago

Chartier, Cecile, Janak Raval, Fumiko Axelrod, Chris Bond, Jennifer Cain, Cristina Dee-Hoskins, Shirley Ma, et al. 2016. “Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.” Cancer Research 76 (3): 713–23. doi:10.1158/0008-5472.CAN-15-0561.